9 Meters Biopharma, Inc. - Special Call Transcript

Aug 18, 2020 / 03:00PM GMT
Operator

Ladies and gentlemen, thank you for joining us for the Catalyst Conference Call Series with 9 Meters Biopharma. My name is Chach, and I'll be the coordinator for this conference. (Operator Instructions)

I'd now like to hand over to Kripa Devarakonda to begin the call. Kripa, please go ahead.

Srikripa Devarakonda - Truist Securities, Inc., Research Division - Associate

Thank you so much, Chach. Good morning, everyone. My name is Kripa Devarakonda, and I cover biotech stocks at Truist Securities. I hope all of you are continuing to stay safe and sane in these turbulent times, and thank you so much for joining us on our Catalyst Conference Call Series today. Today, we're kicking off this series with 9 Meters Biopharma, which I co-cover with Robyn Karnauskas, who's the senior analyst at Truist Securities.

We're very happy to host the entire management team, which includes CEO, John; CFO, Ed; CMO, Patrick; and VP of Business Development, Sireesh. For those of you who are not familiar with the company, 9 Meters Biopharma is a clinical stage company,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot